Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
An experimental version of CAR-T therapy doubled the survival time for children a deadly and aggressive form of brain cancer called DIPG.
An experimental version of CAR-T therapy doubled the survival time for children a deadly and aggressive form of brain cancer called DIPG.
What's Your Reaction?
